The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator.
about
Effects of Glycosylation on the Enzymatic Activity and Mechanisms of ProteasesSerum glycoprotein-derived N- and O-linked glycans as cancer biomarkersGlycopeptide synthesis and the effects of glycosylation on protein structure and activity.Capillary zone electrophoresis of glycopeptides under controlled electroosmotic flow conditions coupled to electrospray and matrix-assisted laser desorption/ionization mass spectrometry.Carbohydrates and activity of natural and recombinant tissue factorExploiting topological constraints to reveal buried sequence motifs in the membrane-bound N-linked oligosaccharyl transferases.Quantitation of permethylated N-glycans through multiple-reaction monitoring (MRM) LC-MS/MSAnalytical detection and characterization of biopharmaceutical glycosylation by MS.Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.Analysis of glycans derived from glycoconjugates by capillary electrophoresis-mass spectrometry.Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine DesignQuantitative glycomics strategiesIdentifying cancer biomarkers by mass spectrometry-based glycomicsDefining putative glycan cancer biomarkers by MS.The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulumA target-specific approach for the identification of tyrosine-sulfated hemostatic proteins.The Periplasmic Chaperone Network of Campylobacter jejuni: Evidence that SalC (Cj1289) and PpiD (Cj0694) Are Involved in Maintaining Outer Membrane Integrity.N-glycoprotein macroheterogeneity: biological implications and proteomic characterization.Biological roles of glycans.X-ray crystallographic studies of the extracellular domain of the first plant ATP receptor, DORN1, and the orthologous protein from Camelina sativa.Biophysical characterization of fungal phytases (myo-inositol hexakisphosphate phosphohydrolases): molecular size, glycosylation pattern, and engineering of proteolytic resistance.Differential glycosylation of gelatinase B from neutrophils and breast cancer cells.Polyethyleneimine-modified graphene oxide nanocomposites for effective protein functionalization.A family of novel, acidic N-glycans in Bowes melanoma tissue plasminogen activator have L2/HNK-1-bearing antennae, many with sulfation of the fucosylated chitobiose core.Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.Asparagine-linked oligosaccharides protect Lamp-1 and Lamp-2 from intracellular proteolysis.High-temperature LC-MS/MS of permethylated glycans derived from glycoproteinsStudying the glycan moiety of RNase B by means of Raman and Raman optical activity.Quantitative LC-MS/MS Glycomic Analysis of Biological Samples Using AminoxyTMT.Expression of Escherichia coli AppA2 phytase in four yeast systems.Comparison of the diphtheria mutant toxin, CRM197, with a Haemophilus influenzae type-b polysaccharide-CRM197 conjugate by optical spectroscopy.Serum sialylation changes in cancer.Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase
P2860
Q28069869-5BAFAFB0-EBAE-4644-B081-1A968BECD6E7Q28079101-1542E517-2612-4010-9567-BA4D3DC76CB9Q30329539-406C61D7-2B5C-4FD4-9F67-512E60734EF6Q33235762-3DE22615-EFA2-465B-9B6B-783A5BBC03D0Q33517083-255D383F-8976-42F7-A598-00910943DA75Q35188301-8C8AF147-0C35-4BB2-AB50-203683629F1EQ35886419-16366C52-3C83-4EA1-B79B-5CC7DC00F58EQ35953047-FE8A5EAC-0D7C-40A0-A022-56D33FCD8629Q35975965-A3AA86BB-97E2-4540-B792-1BB0D7B206E4Q35988418-7F24A5BD-BBE4-46A5-8105-70384D013A7BQ36447540-38017DF4-9E54-42C9-8A92-3386511048C3Q36742414-E94DB1B4-9569-45A3-A351-960EA4EA04F6Q36904006-1F763314-EF38-428D-892A-2164D4CA21A8Q36904030-944CF02C-4FE2-4F5A-AF01-D4B80AED8278Q37100233-6E24F631-ABEE-4135-AD9D-1E43FEA0B1C0Q37226512-F7DEE75C-6075-4B6A-8583-575E9149B205Q37723502-B4105ECE-E2ED-4BFC-8482-3A0C164F2FB7Q38659790-D3E19E2F-BA78-4473-B129-394B8BE2C191Q38936714-30E41EF1-293F-408B-AC2A-185809B91E63Q39316761-4D31ABD4-1ACF-487F-BAD8-372D977711E4Q39480166-6B117E45-0ECA-4D6E-845D-0419DA249485Q40332446-8E15CC0F-6761-4EE0-B516-5E19314E858EQ40661460-62D7D115-E4EB-47D3-8935-837381CF2B22Q40792543-4CB426FF-0965-4C46-B36A-B1BE6B0B3A0AQ40872026-7FCB4213-DD85-45FC-B71F-DEF711D06FFBQ40923003-F2D524E0-6FAB-431A-9CFB-DCFA74ADED11Q41995518-6AC0D807-481E-471D-AAF0-FC1BC60344B6Q43659093-4352972A-0451-4508-B7A0-C6D448E1325DQ46179636-F93C53E9-0CC2-44D4-81C4-CAD15C18EDCBQ46441112-99FAEE46-36F8-4C9F-BAD6-930C6BC7095AQ53968723-4B74AAE0-664C-447C-A24C-EF75978DF4A3Q55410162-E2A39B7D-1BD2-4076-9914-66F97A9FB7BFQ56395838-AA3E4638-DCB2-452A-B7D9-12C581D0A95A
P2860
The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The effects of variable glycos ...... tissue plasminogen activator.
@en
type
label
The effects of variable glycos ...... tissue plasminogen activator.
@en
prefLabel
The effects of variable glycos ...... tissue plasminogen activator.
@en
P2093
P1476
The effects of variable glycos ...... d tissue plasminogen activator
@en
P2093
P356
10.1016/0167-4838(94)00230-E
P407
P577
1995-04-01T00:00:00Z